However, a previous study showed that IFITM1 plays an important role during invasion at the early stage of head and neck squamous cell carcinoma (HNSCC) progression, and IFITM1 can be a therapeutic target for HNSCC [30]. Here, IFITM1 is linked to head and neck squamous cell carcinoma.